gossypol and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

gossypol has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Cavalli, A; Myers, SH; Ortega, JA	1
El-Hefnawy, T; Kilic, A; Landreneau, RJ; Luketich, JD; Schuchert, MJ	1

Reviews

1 review(s) available for gossypol and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

Article	Year
Synthetic Lethality through the Lens of Medicinal Chemistry. Journal of medicinal chemistry, 2020, 12-10, Volume: 63, Issue:23 Topics: Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinases; DNA-Activated Protein Kinase; Genes, BRCA2; Humans; Neoplasms; Poly(ADP-ribose) Polymerases; Precision Medicine; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Rad51 Recombinase; Synthetic Lethal Mutations	2020

Article

Year

Synthetic Lethality through the Lens of Medicinal Chemistry.

Journal of medicinal chemistry, 2020, 12-10, Volume: 63, Issue:23

Topics: Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinases; DNA-Activated Protein Kinase; Genes, BRCA2; Humans; Neoplasms; Poly(ADP-ribose) Polymerases; Precision Medicine; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Rad51 Recombinase; Synthetic Lethal Mutations

2020

Other Studies

1 other study(ies) available for gossypol and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

Article	Year
Efficacy of signal pathway inhibitors alone and in combination with Cisplatin varies between human non-small cell lung cancer lines. The Journal of surgical research, 2009, Jun-01, Volume: 154, Issue:1 Topics: Carcinoma, Non-Small-Cell Lung; Celecoxib; Cell Line, Tumor; Chromones; Cisplatin; Cyclooxygenase Inhibitors; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Gossypol; Humans; Lung Neoplasms; Morpholines; Pyrazoles; Signal Transduction; Sulfonamides	2009

Article

Year

Efficacy of signal pathway inhibitors alone and in combination with Cisplatin varies between human non-small cell lung cancer lines.

The Journal of surgical research, 2009, Jun-01, Volume: 154, Issue:1

Topics: Carcinoma, Non-Small-Cell Lung; Celecoxib; Cell Line, Tumor; Chromones; Cisplatin; Cyclooxygenase Inhibitors; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Gossypol; Humans; Lung Neoplasms; Morpholines; Pyrazoles; Signal Transduction; Sulfonamides

2009